# Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease

> **NCT06539624** · NA · RECRUITING · sponsor: **The Children's Hospital of Zhejiang University School of Medicine** · enrollment: 12 (estimated)

## Conditions studied

- Fabry Disease

## Interventions

- **GENETIC:** EXG110 injection

## Key facts

- **NCT ID:** NCT06539624
- **Lead sponsor:** The Children's Hospital of Zhejiang University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-10-16
- **Primary completion:** 2027-04-09
- **Final completion:** 2027-04-09
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06539624

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06539624, "Evaluate the Safety and Preliminary Efficacy of EXG110 in Subjects With Fabry Disease". Retrieved via AI Analytics 2026-07-23 from https://api.ai-analytics.org/clinical/NCT06539624. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*